Navigation Links
Access Pharmaceuticals Updates MuGard Website With First Patient Testimonial Video
Date:12/3/2010

DALLAS and NEW YORK, Dec. 3, 2010 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has updated its lead product website, www.MuGard.com, with its first patient MuGard experience testimonial video and additional clinician feedback.  

The video can be found under the Testimonial section of the MuGard website (www.MuGard.com), or by clicking on the following link: www.MuGard.com/testimonials/.

"We continue receiving many anecdotal feedback and testimonials from patients, doctors, and nurses," said Frank Jacobucci, VP of Sales and Marketing, Access Pharmaceuticals.  He continued, "We are gratified at the overwhelmingly positive reception MuGard is receiving in the oncology community and we plan to continue updating the site with additional testimonials that demonstrate the significant clinical benefit experienced using MuGard in both a prophylactic and treatment setting."

About Access:Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products include MuGard™ (www.MuGard.com), which has received FDA marketing clearance for the management of patients with mucositis, ProLindac™, a second generation DACH Platinum in Phase 2 clinical testing of patients with ovarian cancer, and Thiarabine
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Consolidated Portland, Maine Healthcare Market Will Hamper Pharmaceutical Reps Access to Physicians
2. Consortium on Intraosseous (IO) Vascular Access Recommends IO Access for Emergent and Nonemergent Situations
3. Reportlinker Adds Global HPLC Systems & Accessories Industry
4. Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010
5. Access Pharmaceuticals Presents CobOral™ Insulin Research at 10th Annual Diabetes Technology Meeting on November 11-13, 2010
6. Access Pharmaceuticals to Present at LifeTech Capital Miami Medical Investors Conference on November 12th
7. Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa
8. Seven U.S. Medical Centers Commence Study to Change Femoral Artery Cath Lab Access with the First Alternative to the Seldinger Technique in 51 Years
9. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
10. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
11. Access Pharmaceuticals Signs Agreement With Leading Biopharmaceutical Company to Develop CobOral™ Formulation of Widely-Marketed Injectable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 Apnea Sciences ( www.apneasciences.com ) ... Aliso Viejo , California.  Jimmy ... tremendous growth and worldwide expansion, a new facility with ... the anti snore cure have exceeded our expectations and ... are now in 23 countries and will be increasing ...
(Date:12/22/2014)... MEMPHIS, Tenn. , Dec. 22, 2014   ... only automated, no-touch UV disinfection robot, announced today that ... GSA Schedule contract through November 2019.   ... to rapidly engage all levels of government purchasers, including ... facilities, as well as Homeland Security contacts purchasing solutions ...
(Date:12/22/2014)...  ConvaTec, a privately-held medical products and technologies company, ... Chief Executive Officer of the company, effective December 22, ... .  "The Board of Directors of ConvaTec thanks Mr. ... past three years," said Magnus Lundberg , the ... that the company is well positioned for the future."  ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... SAN DIEGO, Oct. 27 Orexigen® Therapeutics, Inc. (Nasdaq: ... (ITT) analyses from the COR-I and COR-II Phase 3 trials ... stage Orexigen candidates for the treatment of obesity. These ... findings from a panel discussion on Saturday where the Company ...
... from a phase II study demonstrated that oral ... frequency of bowel movements in patients with opioid-induced ... an oral peripherally-acting opioid antagonist, is an investigational ... of opioid-induced constipation. , (Logo: ...
Cached Medicine Technology:Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 2Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 3Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 4Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 5Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 6Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego 2Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego 3Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego 4
(Date:12/24/2014)... 2014 Dr. Svetlana Gomer, MGS Tewksbury ... nation gathered with US Marines on November 14, 2014 ... for the Toys for Tots Literacy Program. This ... new books and audio books for the Toys for ... this Christmas. It represents another major strike in the ...
(Date:12/24/2014)... The report offers details on the global sports ... such as the key trends, the orthopedic market, the ... U.S. sports medicine, the impact of the global economy ... by the market. , Browse report with table of ... provides an overview of the global as well as ...
(Date:12/24/2014)... GA (PRWEB) December 24, 2014 Verde Pointe ... comical than ever. "Last years homemade Christmas sweater lit ... uglier. The 2014 winner is Tandy Wilson for the ... ugly sweater enthusiast," says Kirk Kimmerling DDS. "She took pictures ... angels on the sweater." , "Every year I ...
(Date:12/24/2014)... FL (PRWEB) December 24, 2014 Dental ... solution for a tooth replacement. They offer the strongest ... several advantages over other forms of tooth replacement. They ... rely on the adjacent teeth for support, and they ... people have been told that they are not suitable ...
(Date:12/24/2014)... Attorneys handling talcum powder cancer lawsuits at ... website, the Talcum Powder Ovarian Cancer Center. ... action lawsuits and ovarian cancer claims. These baby powder ... at their website, which serves as a national public ... are not the same as class action lawsuits,” explains ...
Breaking Medicine News(10 mins):Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3Health News:Sports Medicine Market Report 2014: Global Industry Analysis, Share, Size, Trends, Growth and Forecast report 2Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 4
... (HealthDay News) -- Some HIV patients experience memory loss ... suggests that the reason why is because the virus ... of supporting brain cells called astrocytes. The blood-brain ... the brain from harmful chemicals and toxins. In healthy ...
... teaming up to offer one of the nation,s most ... Led by the University of Maryland and the ... will target the so-called short-haul "drayage" fleet that shuttles ... The effort seeks to double the impact of ...
... News) -- Cancer patients taking the drugs sunitinib and ... the drugs don,t cause as much damage to the ... small study included 40 volunteers in the Netherlands, including ... were treated with sorafenib. Seven patients with metastatic renal ...
... Kathleen Doheny HealthDay Reporter , TUESDAY, June 28 ... more than most experts have long believed, according to a ... follow-up of nearly three decades -- the longest ever -- ... clearer as the decades roll on. In fact, most ...
... 2011 Earl L. Smith III, O.D., dean of the ... received an award for his work in slowing the progression ... the endowed Greeman-Petty Professor chair, accepted the Donald Korb Award ... lens and cornea section of the American Optometric Association (AOA). ...
... & Science University have discovered a naturally occurring disease in ... a discovery that could have a major impact on ... The disease that the researchers discovered in monkeys at OHSU,s ... virus that could give significant clues into how multiple sclerosis ...
Cached Medicine News:Health News:Research Sheds Light on Cause of Brain Deficits in HIV Patients 2Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 2Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 3Health News:Certain Cancer Drugs Don't Interfere With Flu Vaccine: Study 2Health News:Longest Trial Ever Confirms Mammograms' Benefits 2Health News:Longest Trial Ever Confirms Mammograms' Benefits 3Health News:Work to slow progression of nearsightedness in children wins award 2Health News:Researchers at Oregon Health & Science University discover MS-like disease in monkeys 2
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Sol, 80 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
... Pachymeter [i.e., PalmScan P2000] device is ... which incorporates A-mode pulsed-echo ultrasound,technology, and ... measure the corneal thickness (CT) and,epithelium ... P2000 includes two software user,interfaces; a ...
Medicine Products: